23 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
36
Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation.

China Pharmaceutical University
3
Cladophorol-A is an inhibitor of cyclic GMP-AMP synthase.

The Scripps Research Institute
35
Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided Hybridization.

Ventus Therapeutics
15
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.

Children's Hospital Affiliated to Zhengzhou University
6
Novel Azepino[4,5-b]indolone as cGAS Inhibitors for Treating Immune-Mediated Diseases.

Smith, Gambrell & Russell
10
Inhibitors of the Cyclic GMP-AMP Synthase (cGAS) as Potential Treatment for Autoimmune and Inflammatory Diseases.

PI Health Sciences
42
Design, Synthesis, and Pharmacological Evaluation of Spiro[carbazole-3,3'-pyrrolidine] Derivatives as cGAS Inhibitors for Treatment of Acute Lung Injury.

Shanghai Jiao Tong University
3
STING antagonists, synthesized

Purdue University
19
A closer look at N

Monash University Malaysia
14
Small molecules targeting cGAS-STING pathway for autoimmune disease.

Shanghai Jiao Tong University
25
Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors.

Roche Innovation Center Shanghai
52
Synthesis and Pharmacological Evaluation of Tetrahydro-γ-carboline Derivatives as Potent Anti-inflammatory Agents Targeting Cyclic GMP-AMP Synthase.

Shanghai Institute of Materia Medica (Simm)
4
Fragment-to-Lead Medicinal Chemistry Publications in 2017.

Astex Pharmaceuticals
7
Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay.

Pfizer
29
Macrocyclic spiropyrrolidine derived antiviral agents

Enanta Pharmaceuticals
7
COMPOUND SERVING AS MASP-2 INHIBITOR, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF

Wuhan Createrna Science And Technology Co.
69
N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV 1.7 AND/OR NAV 1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME AND KITS

Eurofarma
63
Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitors

Boehringer Ingelheim International
1
4'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE

Gilead Sciences
288
Naphthyridinone compounds useful as T cell activators

Bristol Myers Squibb
23
Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof

Shanghai Institute of Materia Medica
60
SHP2 INHIBITOR AND COMPOSITION AND APPLICATION THEREOF

Betta Pharmaceuticals
423
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors

Merck Sharp & Dohme